申请人:ALFA WASSERMANN S.p.A.
公开号:EP0620210A1
公开(公告)日:1994-10-19
This invention refers to compounds with benzamidic structure of general formula
and their pharmacologically accepted salts.
The derivatives described in this invention are active in the gastro-intestinal apparatus; in particular, they have prokinetic effects, in other words they create specific stimulation on gastro-intestinal motility, facilitating the passage of the content of the alimentary tract, and possess anti-emetic qualities, without side effects involving the central nervous system.
这项发明涉及一般公式的苯甲酰胺结构化合物及其药理学上可接受的盐。本发明中描述的衍生物在胃肠道器官中具有活性;特别地,它们具有促动力作用,换句话说,它们对胃肠道蠕动产生特定刺激,促进食道道内容物的通过,并具有抗恶心特性,而不涉及中枢神经系统的副作用。